(Date:9/5/2008)..., Va., Sept. 5 /PRNewswire/ -- On Saturday, Septem... on the Oxygen Network show Today,s,Family as part...hted as a,leading medical device company that prov...ive nebulizers and compressors that deliver needed...is to improve the lives of those affected by respi...
(Date:9/5/2008)... finds sorafenib helps reverse disease resistance ...t. 5 (HealthDay News) -- The drug sorafenib may he...anti-hormonal drugs, Georgetown University Medica...-receptor or progesterone-receptor positive (ER or... anti-hormonal medicines, such as aromatase inhibi...
(Date:9/4/2008)...NS, N.Y., Sept. 5 /PRNewswire/ -- A groundbreaking...mental and emotional status of,men, their shorter ...d,medical needs will take place Wednesday, Septemb...the auspices of members of the Westchester,medical...arianne J. Legato,M.D. and Lionel Tiger, Ph.D., ...
(Date:9/4/2008)...p sequence of instructions they say could help doc...4 (HealthDay News) -- Vaccine safety experts say t...an receive vaccinations with close monitoring and ...the September issue of Pediatrics , a team of exp...t forth a step-by-step set of instructions -- an a...
Breaking Medicine News(10 mins):Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Drug Re-Sensitizes Breast Tumors to Treatment 2Health News:Even Kids With Known Allergies Can Be Safely Vaccinated 2...free condoms for nearly 9 months will soon be prov...// the New York city logo as a promotional offer. ...buted since June, according to health officials. ...th Department, New York city, just in time during ...
...ands, from Schools and colleges have sent postcard...t the proposed scrapping of Clemenceau, the French...p-breaking yard. // The Indian arm of Greenpeace ...ists, is spearheading the protest, expressing the ...
...carried a paper that gives us a different depth in... they are in the female reproductive tract. //This...etics of successful fertilization. Previous theor...ly quiet in the female reproductive tract. Gur and...
...stival, hot air balloon festival for 2 weeks, inau... been the joint efforts of Rajasthan Tourism and E...ng from 11countries are participating, who will be...tourism secretary, Vinod Zutshi has expressed happ...
Other Medicine News:(Date:9/4/2008)...hed in ,The Lancet, and Presented at ESC Congress-...rom a new international,study, the GISSI Heart Fai...mega-3 acid ethyl esters reduced all cause mortali...ons in patients with chronic heart,failure. These ...on of ,The,Lancet, and were presented at the Europ...
(Date:9/4/2008)...s to Enroll 750 Women at More Than 100 Sites in th... QuatRx Pharmaceuticals, a,privately-held biopharm...rcialization of compounds to treat endocrine, meta...d that it has initiated a second,Phase 3 clinical ...any,s,estrogen-free oral therapy in development fo...
(Date:9/4/2008)...onstrates potent antiviral activity and favorable ...AMBRIDGE, Mass., Sept. 4 /-...biopharmaceutical company engaged,in the discovery...an viral,and other infectious diseases, today anno...tudy evaluating IDX899, a non-nucleoside reverse,t...
(Date:9/3/2008)...ia, Sept. 4 /Xinhua--,Pharm...L) today announced,that it has enrolled the first ...rial evaluating Bronchitol in cystic fibrosis suff...1 hospitals across North,America, Argentina and Ge...axis seeks approval to market Bronchitol for cysti...
Breaking Medicine Technology:New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Leading Lobbying Firm Celebrates Growth and New Name 3A Troutman Sanders Strategies 6702 1Leading Lobbying Firm Celebrates Growth and New Name 3A Troutman Sanders Strategies 6702 2Paying to save tropical forests could be a way to reduce global carbon emissions 4180 1Paying to save tropical forests could be a way to reduce global carbon emissions 4180 2Paying to save tropical forests could be a way to reduce global carbon emissions 4180 3Paying to save tropical forests could be a way to reduce global carbon emissions 4180 4Varian Inc Reports Third Quarter 2008 Results 6697 1Varian Inc Reports Third Quarter 2008 Results 6697 2Varian Inc Reports Third Quarter 2008 Results 6697 3Varian Inc Reports Third Quarter 2008 Results 6697 4Varian Inc Reports Third Quarter 2008 Results 6697 5Varian Inc Reports Third Quarter 2008 Results 6697 6Varian Inc Reports Third Quarter 2008 Results 6697 7Varian Inc Reports Third Quarter 2008 Results 6697 8Varian Inc Reports Third Quarter 2008 Results 6697 9Varian Inc Reports Third Quarter 2008 Results 6697 10Varian Inc Reports Third Quarter 2008 Results 6697 11Varian Inc Reports Third Quarter 2008 Results 6697 12Varian Inc Reports Third Quarter 2008 Results 6697 13Varian Inc Reports Third Quarter 2008 Results 6697 14Varian Inc Reports Third Quarter 2008 Results 6697 15Varian Inc Reports Third Quarter 2008 Results 6697 16Varian Inc Reports Third Quarter 2008 Results 6697 17Varian Inc Reports Third Quarter 2008 Results 6697 18Varian Inc Reports Third Quarter 2008 Results 6697 19Varian Inc Reports Third Quarter 2008 Results 6697 20Varian Inc Reports Third Quarter 2008 Results 6697 21Varian Inc Reports Third Quarter 2008 Results 6697 22Varian Inc Reports Third Quarter 2008 Results 6697 23Varian Inc Reports Third Quarter 2008 Results 6697 24Varian Inc Reports Third Quarter 2008 Results 6697 25Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2008 Financial Results 6694 1Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2008 Financial Results 6694 2...hoc analysis shows nearly nine out of ten patients... the end of 12 months, WASHINGTON, D.C., May 22, 2...I, open-label 12-14 month extension study (303),pr... (BSG) meeting,in Glasgow, Scotland in March 2007 ...rated in mild to moderate UC,patients. Today, seco...
...n Antibody Led to a Sustained Response and Remissi...nd Was Adequately,Tolerated in Patients with IV St...f., May 22, 2007 /PRNewswire-FirstCall/ -- Data,pr...g this week in,Washington D.C. by Dr. William Sand...ilizumab), an antibody in development as a,treatme...
Other Medicine Technology:Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 2PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 3PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 4PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 5Pre-set guard for precise depth incision, bi-directional blade can cut left or right. 250 micron.
BD Beaver Fixation Rings
Tips are sharp on both sides to puncture, cut and tear the capsule
BD Visitec J Shape Cannulas
Medicine Products: